Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Ruth H Green¹, Christopher E Brightling, Susan McKenna

¹Institute for Lung Health, Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, LE3 9PQ, Leicester, UK.

Lancet (London, England)

|December 14, 2002

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort.

EBioMedicine·2026

Same author

Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study.

The Lancet. Respiratory medicine·2026

Same author

Reply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.

American journal of respiratory and critical care medicine·2026

Same author

Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA Trials.

American journal of respiratory and critical care medicine·2026

Same author

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Lancet (London, England)·2026

Same author

Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial.

The Lancet. Respiratory medicine·2026

Managing asthma by monitoring sputum eosinophils, a marker of airway inflammation, significantly reduced exacerbations and hospitalizations compared to standard guidelines. This targeted approach improves asthma control without increasing steroid use.

Area of Science:

Pulmonary Medicine
Allergy and Immunology
Clinical Research

Background:

Current asthma management relies on symptoms and lung function, which inadequately reflect eosinophilic airway inflammation.
A disconnect exists between standard asthma care metrics and the underlying inflammatory processes driving exacerbations.

Purpose of the Study:

To evaluate if a management strategy targeting eosinophilic airway inflammation reduces asthma exacerbations compared to standard care.
To determine the efficacy of sputum eosinophil count normalization in controlling asthma severity.

Main Methods:

A randomized controlled trial involving 74 patients with moderate to severe asthma.
Comparison between standard British Thoracic Society (BTS) guidelines and a sputum management strategy focused on normalizing eosinophil counts.

More Related Videos

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

Related Experiment Videos

Last Updated: Jul 9, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

Intention-to-treat analysis of primary outcomes: severe exacerbations and sputum eosinophil counts over 12 months.

Main Results:

The sputum management group showed a 63% reduction in sputum eosinophil counts over 12 months (p=0.002).
Patients managed by sputum eosinophil counts experienced significantly fewer severe asthma exacerbations (35 vs. 109, p=0.01) and hospital admissions (1 vs. 6, p=0.047).
No significant difference in corticosteroid dosage was observed between the groups.

Conclusions:

A treatment strategy guided by induced sputum eosinophil counts effectively reduces asthma exacerbations and hospital admissions.
This approach achieves improved asthma control without necessitating increased anti-inflammatory medication.